These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35918642)

  • 1. Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis.
    Wu J; Li N; Zhu L; Zhen D; Li M; Chen H; Ye M; Wei Y; Shao G
    BMC Bioinformatics; 2022 Aug; 23(1):312. PubMed ID: 35918642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.
    Kim H; Cho U; Hong SH; Park HS; Kim IH; An HJ; Shim BY; Kang JH
    Oncol Res; 2024; 32(6):1021-1030. PubMed ID: 38827321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
    Tokunaga E; Yamashita N; Tanaka K; Inoue Y; Akiyoshi S; Saeki H; Oki E; Kitao H; Maehara Y
    PLoS One; 2016; 11(12):e0168090. PubMed ID: 27977754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.
    Xia S; Gu Y; Zhang H; Fei Y; Cao Y; Fang H; Wang J; Lin C; Zhang H; Li H; He H; Xu J; Li R; Liu H; Zhang W
    Oncoimmunology; 2021; 10(1):1975386. PubMed ID: 34552824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
    McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
    J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
    Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
    Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
    Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of APOBEC3B in chondrosarcoma.
    Jin Z; Han YX; Han XR
    Oncol Rep; 2014 Nov; 32(5):1867-72. PubMed ID: 25176183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Significance of APOBEC3B and PD-L1/PD-1 in Nasopharyngeal Carcinoma.
    Feng C; Zhang Y; Huang J; Zheng Q; Yang Y; Xu B
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):239-244. PubMed ID: 32205739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
    Fan Q; Huang T; Sun X; Wang YW; Wang J; Liu Y; Ni T; Gu SL; Li YH; Wang YD
    Mol Carcinog; 2021 May; 60(5):313-330. PubMed ID: 33631046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
    Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
    Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3B: a potential factor suppressing growth of human hepatocellular carcinoma cells.
    Wu PF; Chen YS; Kuo TY; Lin HH; Liu CW; Chang LC
    Anticancer Res; 2015 Mar; 35(3):1521-7. PubMed ID: 25750306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute expression of human APOBEC3B in mice results in RNA editing and lethality.
    Alonso de la Vega A; Temiz NA; Tasakis R; Somogyi K; Salgueiro L; Zimmer E; Ramos M; Diaz-Jimenez A; Chocarro S; Fernández-Vaquero M; Stefanovska B; Reuveni E; Ben-David U; Stenzinger A; Poth T; Heikenwälder M; Papavasiliou N; Harris RS; Sotillo R
    Genome Biol; 2023 Nov; 24(1):267. PubMed ID: 38001542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.
    Zhang X; Wu Z; Hao Y; Yu T; Li X; Liang Y; Li J; Huang L; Xu Y; Li X; Xu X; Wang W; Xu G; Zhang X; Lv Q; Fang Y; Xu R; Qian W
    Front Immunol; 2022; 13():888250. PubMed ID: 35592333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
    He L; Yang B; Jian D; Luo H; Wang D; Dai N
    Dis Markers; 2022; 2022():2147494. PubMed ID: 35903294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.